Press Release Distributed by ABNewswire.com To view the original version on ABNewswire visit: New Data: “Admission-First” AI ...

In a new publication, researchers from the German Center for Diabetes Research (DZD) and the University of Medicine ...

A new working paper has found that one-third of all data points collected in 105 phase 2 and 3 trials were not needed for the studies’ key analyses, while also highlighting how an increase in clinical ...

JOURNAVX met the primary endpoint by demonstrating statistically significant superior reduction in pain vs placebo. 1,b JOURNAVX did not meet the first key secondary endpoint that hypothesized ...

While Silicon Valley pours billions into longevity tech and concierge medicine for the ultra-wealthy, OMNY Health is building something far more radical: a data infrastructure that can actually ...

Physicians, struggling under the pressure of heavy patient loads amidst a national clinical workforce shortage, continue to rank working with EHR systems as the second most challenging part of the job ...

Clinical trials continue to be a driving force in ophthalmology, propelling the development of innovative treatments and ...

This article is part of our series on clinical data considerations. Read How to Approach Fundraising and Investor Relations. When it comes to disclosing clinical trial data in the biotechnology arena, ...

BioNTech will present significant clinical trial data at the prestigious ASCO Annual Meeting, highlighting the advancement of its diversified oncology portfolio. The preliminary results for BNT327 and ...

Their solution, VetEvince, went beyond simple automation or AI chat assistants. It promised to deliver insights anchored in ...